Home › Funds › FARALLON CAPITAL MANAGEMENT, L.L.C. › EXEL
FARALLON CAPITAL MANAGEMENT, L.L.C. position in EXEL
EXELIXIS INC · Health Care
FARALLON CAPITAL MANAGEMENT, L.L.C. reported holding 14,694,910 shares of EXEL (EXELIXIS INC) in its Q3 2026 13F filing — a position valued at US$858.3M, representing 3.80% of its reported portfolio and ranking #7 among its reported holdings. FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed EXEL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How FARALLON CAPITAL MANAGEMENT, L.L.C.'s EXEL position evolved
FARALLON CAPITAL MANAGEMENT, L.L.C. first disclosed a stake in EXEL in Q3 2023 at 25,860,000 shares (US$565.0M). The position peaked in Q3 2026 at 14,694,910 shares, worth US$858.3M. Across 13 filings, FARALLON CAPITAL MANAGEMENT, L.L.C. increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 14,694,910 shares valued at US$858.3M — an increase of 1,226,900 shares quarter over quarter.. Notable position changes include a 29% trim in Q2 2025 (shares fell 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 25.86M | $565.04M | New |
| Q4 2023 | 26.63M | $638.96M | Add |
| Q1 2024 | 26.68M | $633.08M | Hold |
| Q2 2024 | 27.10M | $608.99M | Add |
| Q3 2024 | 25.41M | $659.40M | Reduce |
| Q4 2024 | 23.44M | $780.54M | Reduce |
| Q1 2025 | 22.53M | $831.94M | Reduce |
| Q2 2025 | 16.04M | $706.76M | Reduce |
| Q3 2025 | 19.50M | $805.41M | Add |
| Q4 2025 | 15.71M | $688.55M | Reduce |
| Q1 2026 | 13.11M | $562.33M | Reduce |
| Q2 2026 | 13.47M | $732.79M | Add |
| Q3 2026 | 14.69M | $858.33M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EXEL and 13F data
EXEL (EXELIXIS INC) is a Health Care company. 39 other funds we track also report a position in EXEL — the largest reported positions include Renaissance Technologies (US$747.2M), Farallon Capital Management (US$732.8M), FULLER & THALER ASSET MANAGEMENT, INC. (US$513.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EXEL
- Renaissance Technologies 12.79M sh · $747.22M · Q3 2026
- Farallon Capital Management 13.47M sh · $732.79M · Q2 2026
- FULLER & THALER ASSET MANAGEMENT, INC. 8.80M sh · $513.77M · Q3 2026
- D. E. Shaw & Co., Inc. 5.55M sh · $302.07M · Q2 2026
- Stephens Investment Management Group LLC 2.60M sh · $151.65M · Q3 2026
- Caligan Partners LP 1.55M sh · $84.51M · Q2 2026
More on FARALLON CAPITAL MANAGEMENT, L.L.C.
FAQ
How long has FARALLON CAPITAL MANAGEMENT, L.L.C. held EXEL?
FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed EXEL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is FARALLON CAPITAL MANAGEMENT, L.L.C.'s current position in EXEL?
As of Q3 2026, FARALLON CAPITAL MANAGEMENT, L.L.C. holds 14.69M shares of EXEL (EXELIXIS INC), valued at $858.33M, representing 3.80% of its reported portfolio and ranking #7.
Has FARALLON CAPITAL MANAGEMENT, L.L.C. been buying or selling EXEL?
In the latest 13F filing (Q3 2026), FARALLON CAPITAL MANAGEMENT, L.L.C. increased its position in EXEL. The position peaked in Q3 2026 at 14.69M shares.
Which other funds hold EXEL?
Other major institutional holders of EXEL include Renaissance Technologies, Farallon Capital Management, FULLER & THALER ASSET MANAGEMENT, INC., among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.